2015
DOI: 10.1016/j.gene.2015.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Compound heterozygous protein C deficiency in a family with venous thrombosis: Identification and in vitro study of p.Asp297His and p.Val420Leu mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 23 publications
1
9
0
Order By: Relevance
“…The onset age and mode of the late‐onset patients with double mutations were varied. Late‐onset patients with the double mutations of PROC are rarely reported in Caucasians but are increasing in number in Asian countries (Table ). This discrepancy may be due to the high allelic frequency of FV Leiden and FII variant in Caucasians, which hampers the detection of rare double PROC mutations in adult patients.…”
Section: Discussionmentioning
confidence: 99%
“…The onset age and mode of the late‐onset patients with double mutations were varied. Late‐onset patients with the double mutations of PROC are rarely reported in Caucasians but are increasing in number in Asian countries (Table ). This discrepancy may be due to the high allelic frequency of FV Leiden and FII variant in Caucasians, which hampers the detection of rare double PROC mutations in adult patients.…”
Section: Discussionmentioning
confidence: 99%
“…COS7 cells were used to present the receptor’s subcellular localization because of its prominent membrane structure that makes it easy to distinguish the specific location of V2R proteins. WT-V2R and I324M-V2R were co-stained with protein disulfide isomerase (PDI) and Golgi marker (GM130), which are used as the markers of endoplasmic reticulum (ER) and Golgi apparatus, respectively 25 . As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, qualitative PCD was previously observed in carriers of other mutations at position 385, 420, and 423. [23][24][25] In the type I mutation category, p. Asn371Asp was considered to be "likely pathogenic," despite its high frequency (gnomAD: 0.03%) and low in silico prediction scores, for two main reasons. First, Asn 371 is one of the four N-linked glycosylation sites of PC and another mutation at It has been previously reported in case-control studies of VTE that two polymorphisms in the promoter region of PROC (-228C > T and -215G > A) had a significant influence on PC level and risk of VTE.…”
Section: Genotype and Pc Phenotypementioning
confidence: 99%